Long-term Efficacy of Neoadjuvant Chemoradiotherapy Plus Surgery for the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma
2021 · JAMA Surgery · 315 citations
https://doi.org/10.1001/jamasurg.2021.2373
C
Chengchu Zhu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
92
Papers
3.0K
Citations
25
h-index
43
i10-index
Chengchu Zhu is an academic researcher from IHI Corporation (United States). The author has contributed to research in topics: Esophageal Cancer Research and Treatment & Lung Cancer Diagnosis and Treatment & Gastric Cancer Management and Outcomes. The author has an h-index of 25, co-authored 79 publications.
Papers by this author
worksA rapid NGS strategy for comprehensive molecular diagnosis of Birt-Hogg-Dubé syndrome in patients with primary spontaneous pneumothorax
2016 · Respiratory Research · 28 citations
https://doi.org/10.1186/s12931-016-0377-9
The role of ferroptosis in esophageal cancer
2022 · Cancer Cell International · 26 citations
https://doi.org/10.1186/s12935-022-02685-w
Prognosis of primary tracheal tumor: A population‐based analysis
2017 · Journal of Surgical Oncology · 25 citations
https://doi.org/10.1002/jso.24611
Does pathological complete response after neoadjuvant chemoradiotherapy associate with long-term survival in esophageal cancer: A systematic review and meta-analysis
2025 · BMC Surgery · 2 citations
https://doi.org/10.1186/s12893-025-03016-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat